Cytotoxic innate intraepithelial lymphocytes control early stages of


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2023
Historique:
received: 26 05 2023
accepted: 31 07 2023
medline: 26 9 2023
pubmed: 25 9 2023
entrez: 25 9 2023
Statut: epublish

Résumé

Intraepithelial lymphocytes (IELs) are the first immune cells to contact and fight intestinal pathogens such as To better define functions of innate IELs in cryptosporidiosis, we developed a co-culture model with innate IELs isolated from Thanks to this original model, we demonstrated that innate IELs control parasite proliferation. We further showed that although innate IELs secrete IFN-γ in response to Based on these data we conclude that innate IELs, most likely T-cell-like innate IELs, provide a rapid protection against

Sections du résumé

Background
Intraepithelial lymphocytes (IELs) are the first immune cells to contact and fight intestinal pathogens such as
Methods
To better define functions of innate IELs in cryptosporidiosis, we developed a co-culture model with innate IELs isolated from
Results
Thanks to this original model, we demonstrated that innate IELs control parasite proliferation. We further showed that although innate IELs secrete IFN-γ in response to
Conclusion
Based on these data we conclude that innate IELs, most likely T-cell-like innate IELs, provide a rapid protection against

Identifiants

pubmed: 37744354
doi: 10.3389/fimmu.2023.1229406
pmc: PMC10512070
doi:

Substances chimiques

Granzymes EC 3.4.21.-
Antineoplastic Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1229406

Informations de copyright

Copyright © 2023 Hariss, Delbeke, Guyot, Zarnitzky, Ezzedine, Certad and Meresse.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Parasite Immunol. 2013 Feb;35(2):55-64
pubmed: 23173616
Vaccine. 2009 Nov 5;27(47):6575-81
pubmed: 19717136
J Parasitol. 2003 Apr;89(2):270-5
pubmed: 12760640
Immunity. 2014 Sep 18;41(3):451-464
pubmed: 25220211
Crit Rev Immunol. 2021;41(4):23-38
pubmed: 35381141
Infect Immun. 2002 Apr;70(4):2090-9
pubmed: 11895975
Microbes Infect. 2013 Jul-Aug;15(8-9):599-606
pubmed: 23644177
J Parasitol. 1993 Apr;79(2):295-7
pubmed: 8459345
Infect Immun. 1993 Aug;61(8):3548-51
pubmed: 8335387
J Immunol. 1991 Aug 1;147(3):1014-22
pubmed: 1677668
J Infect Dis. 2009 Nov 15;200(10):1548-55
pubmed: 19821721
Infect Immun. 1994 Feb;62(2):697-9
pubmed: 7905464
Am J Med Sci. 2000 Nov;320(5):304-9
pubmed: 11093682
Nat Microbiol. 2018 Jul;3(7):814-823
pubmed: 29946163
J Immunol. 2018 Apr 1;200(7):2235-2244
pubmed: 29555677
Appl Environ Microbiol. 2003 May;69(5):2505-11
pubmed: 12732515
Infect Immun. 2009 Nov;77(11):5044-9
pubmed: 19687195
J Biol Chem. 2014 Mar 28;289(13):9408-17
pubmed: 24505135
J Parasitol. 1999 Apr;85(2):234-9
pubmed: 10219301
Nature. 2009 May 14;459(7244):262-5
pubmed: 19329995
Mucosal Immunol. 2022 Feb;15(2):362-372
pubmed: 34750455
PLoS One. 2019 Jul 10;14(7):e0215883
pubmed: 31291255
Int J Parasitol. 2017 Oct;47(12):711-721
pubmed: 28893638
Infect Immun. 1997 Aug;65(8):3074-9
pubmed: 9234756
J Infect Dis. 2005 Oct 1;192(7):1294-302
pubmed: 16136475
Vet Res. 2015 Mar 11;46:28
pubmed: 25890354
Front Immunol. 2019 Feb 28;10:196
pubmed: 30873151
Cell Mol Immunol. 2020 Apr;17(4):347-355
pubmed: 31471588
J Immunol. 1996 May 15;156(10):3678-86
pubmed: 8621902
Immunity. 2016 Sep 20;45(3):610-625
pubmed: 27612641
Infect Immun. 1990 Apr;58(4):961-9
pubmed: 2108092
Immunity. 2012 Jul 27;37(1):108-21
pubmed: 22705105
Infect Immun. 1996 Jul;64(7):2556-62
pubmed: 8698479
Blood. 2005 Feb 1;105(3):1153-61
pubmed: 15454490
Immunity. 2013 Apr 18;38(4):769-81
pubmed: 23453631
Nat Rev Immunol. 2018 Aug;18(8):514-525
pubmed: 29717233
Infect Immun. 1992 Aug;60(8):3325-31
pubmed: 1639500

Auteurs

Fatima Hariss (F)

Univ. Lille, Inserm, CHU Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation, Lille, France.

Marie Delbeke (M)

Univ. Lille, Inserm, CHU Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation, Lille, France.

Karine Guyot (K)

Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Centre d'Infection et d'Immunité de Lille, University of Lille, Lille, France.

Pauline Zarnitzky (P)

Univ. Lille, Inserm, CHU Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation, Lille, France.

Mohamad Ezzedine (M)

Department of Biology, Faculty of Science, Lebanese University, Beirut, Lebanon.

Gabriela Certad (G)

Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Centre d'Infection et d'Immunité de Lille, University of Lille, Lille, France.
Délégation à la Recherche Clinique et à l'Innovation, Groupement des Hôpitaux de l'Institut Catholique de Lille, Lomme, France.

Bertrand Meresse (B)

Univ. Lille, Inserm, CHU Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation, Lille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs
Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice

Classifications MeSH